Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for prediction prostate cancer patients' resistance to hormonal treatment by measuring serum concentrations of chromogranin A

Method for prediction prostate cancer patients' resistance to hormonal treatment by measuring serum concentrations of chromogranin A

US Patent 6238877 · Granted May 29, 2001

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Olefin plant refrigeration system2004
Olefin plant refrigeration system2003
Assay for determining analyte using mercury release followed by detection via in1992
Medical droplet whole blood and like monitoring1991
Medical droplet whole blood and like monitoring1991
Competitive protein binding assay using an organosilane-silica gel separation me1984